1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Kidney Disease Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Kidney Disease Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Favorable Reimbursement Policy for Kidney Disease Treatments
- 5.1.2 High Prevalence of Chronic Diseases Leading to Kidney Diseases
5.2 Market Opportunities
- 5.2.1 Increase in Preference for Robotic Surgeries for Kidney Diseases
5.3 Future Trends
- 5.3.1 Rise in Preference for Advanced Hemodialysis Therapies
5.4 Impact of Drivers and Restraints
6. Europe Kidney Disease Market Regional Analysis
6.1 Europe Kidney Disease Market Overview
6.2 Europe Kidney Disease Market Revenue 2017-2027 (US$ Million)
6.3 Europe Kidney Disease Market Forecast Analysis
7. Europe Kidney Disease Market Analysis – by Product
7.1 Diagnosis and Treatment
- 7.1.1 Overview
- 7.1.2 Diagnosis and Treatment: Europe Kidney Disease Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Kidney Disease Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Diagnostic Laboratories
- 8.2.1 Overview
- 8.2.2 Diagnostic Laboratories: Europe Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Kidney Disease Market – Europe Analysis
9.1 Europe
- 9.1.1 Europe Kidney Disease Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.1.1.1 Europe Kidney Disease Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 UK:
Europe Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 UK: Europe Kidney Disease Market Breakdown, by Product
- 9.1.1.1.2 UK: Europe Kidney Disease Market Breakdown, by End User
- 9.1.1.2 Germany:
Europe Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Germany: Europe Kidney Disease Market Breakdown, by Product
- 9.1.1.2.2 Germany: Europe Kidney Disease Market Breakdown, by End User
- 9.1.1.3 France:
Europe Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 France: Europe Kidney Disease Market Breakdown, by Product
- 9.1.1.3.2 France: Europe Kidney Disease Market Breakdown, by End User
- 9.1.1.4 Russia:
Europe Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.4.1 Russia: Europe Kidney Disease Market Breakdown, by Product
- 9.1.1.4.2 Russia: Europe Kidney Disease Market Breakdown, by End User
- 9.1.1.5 Italy:
Europe Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.5.1 Italy: Europe Kidney Disease Market Breakdown, by Product
- 9.1.1.5.2 Italy: Europe Kidney Disease Market Breakdown, by End User
- 9.1.1.6 Rest of Europe:
Europe Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.6.1 Rest of Europe: Europe Kidney Disease Market Breakdown, by Product
- 9.1.1.6.2 Rest of Europe: Europe Kidney Disease Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Europe Kidney Disease Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 AbbVieInc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pfizer Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 GlaxoSmithKline plc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Amgen Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Sysmex Corporation
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Siemens AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For Europe Kidney Disease Market
